# To Study the Influence of GCSF on Natural History of Acute On Chronic Liver Failure After the Acute Phase

> **NCT02788240** · NA · TERMINATED · sponsor: **Institute of Liver and Biliary Sciences, India** · enrollment: 14 (actual)

## Conditions studied

- Acute on Chronic Liver Failure

## Interventions

- **DRUG:** Peg GCSF
- **BIOLOGICAL:** 20% Albumin
- **DIETARY_SUPPLEMENT:** Nutrition
- **OTHER:** Bowel wash
- **DRUG:** Terlipressin 1- 4mg,if indicated
- **DRUG:** Meropenem or Imepenem, if indicated
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02788240
- **Lead sponsor:** Institute of Liver and Biliary Sciences, India
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2016-05-01
- **Primary completion:** 2017-07-15
- **Final completion:** 2017-07-15
- **Target enrollment:** 14 (ACTUAL)
- **Last updated:** 2018-02-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02788240

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02788240, "To Study the Influence of GCSF on Natural History of Acute On Chronic Liver Failure After the Acute Phase". Retrieved via AI Analytics 2026-06-13 from https://api.ai-analytics.org/clinical/NCT02788240. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*